However, this group may require more support from a nutritional specialist than most
The strips are also very discreet
Accordingly, approved indications expanded in early 2024 to include not only reduction of hyperglycemia, but also weight management in non-diabetic patients, and even cardiovascular risk reduction in patients with elevated weight and comorbid cardiovascular disease
My suspicion is that most people regain the weight because the treatment was short-term, focused on weight loss rather than developing better habits, and resulted in loss of muscle, which reduces your basal metabolic rate and makes you more likely to gain weight
By the end of 2026, core patents on semaglutide will have expired in 10 countries that represent 48 percent of the global obesity burden, according to a study published earlier this month by researchers
Rare but Serious Risks Although not many people have it, Mounjaro can cause some very serious problems